Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 4:21 pm Sale | 2022-12-31 | 13G | Intersect ENT, Inc. XENT | Versor Investments LP | 0 0.000% | -3,347,165 (Position Closed) | Filing History |
| 2022-03-11 2:13 pm Unchanged | 2021-12-31 | 13G | Intersect ENT, Inc. XENT | BlackRock Inc. BLK | 2,638,333 7.900% | 0 (Unchanged) | Filing History |
| 2022-02-23 08:56 am Sale | 2022-02-14 | 13G | Intersect ENT, Inc. XENT | Versor Investments LP | 3,347,165 10.000% | -21,926 (-0.65%) | Filing History |
| 2022-02-17 11:40 am Purchase | 2022-02-07 | 13G | Intersect ENT, Inc. XENT | Versor Investments LP | 3,369,091 10.070% | 193,994 (+6.11%) | Filing History |
| 2022-02-14 4:41 pm Purchase | 2021-12-31 | 13G | Intersect ENT, Inc. XENT | First Light Asset Management, LLC | 1,381,710 4.130% | 1,381,710 (New Position) | Filing History |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Intersect ENT, Inc. XENT | The Vanguard Group | 1,801,606 5.380% | 136,172 (+8.18%) | Filing History |
| 2022-02-08 5:05 pm Sale | 2021-12-31 | 13G | Intersect ENT, Inc. XENT | BlackRock Inc. BLK | 2,638,333 7.900% | -247,443 (-8.57%) | Filing History |
| 2022-02-08 11:14 am Purchase | 2021-12-31 | 13G | Intersect ENT, Inc. XENT | Versor Investments LP | 3,175,097 9.500% | 1,439,018 (+82.89%) | Filing History |
| 2022-01-31 2:34 pm Purchase | 2021-12-31 | 13G | Intersect ENT, Inc. XENT | GOLDMAN SACHS GROUP INC GS | 2,628,508 7.900% | 2,628,508 (New Position) | Filing History |
| 2021-10-20 4:41 pm Purchase | 2021-10-11 | 13G | Intersect ENT, Inc. XENT | Integrated Core Strategies (US) LLC | 1,630,168 4.900% | 1,586,545 (+3636.95%) | Filing History |
| 2021-10-08 06:18 am Sale | 2021-09-30 | 13G | Intersect ENT, Inc. XENT | Artisan Partners Limited Partnership | 1,454,164 4.400% | -2,314,007 (-61.41%) | Filing History |
| 2021-09-10 09:33 am Sale | 2021-09-09 | 13G | Intersect ENT, Inc. XENT | FMR LLC | 0 0.000% | -3,495,000 (Position Closed) | Filing History |
| 2021-08-19 08:46 am Purchase | 2021-08-09 | 13D | Intersect ENT, Inc. XENT | Magnetar Financial LLC | 2,543,999 7.640% | 2,543,999 (New Position) | Filing History |
| 2021-08-17 3:21 pm Purchase | 2021-08-09 | 13G | Intersect ENT, Inc. XENT | Versor Investments LP | 1,736,079 5.210% | 1,736,079 (New Position) | Filing History |
| 2021-06-10 11:37 am Purchase | 2021-06-09 | 13G | Intersect ENT, Inc. XENT | FMR LLC | 3,495,000 10.545% | 535,000 (+18.07%) | Filing History |
| 2021-04-09 06:13 am Purchase | 2021-03-31 | 13G | Intersect ENT, Inc. XENT | Artisan Partners Limited Partnership | 3,768,171 11.400% | 801,723 (+27.03%) | Filing History |
| 2021-02-12 4:11 pm Sale | 2020-12-31 | 13G | Intersect ENT, Inc. XENT | HealthCor Management L.P. | 0 0.000% | -2,536,760 (Position Closed) | Filing History |
| 2021-02-12 12:35 pm Purchase | 2020-12-31 | 13G | Intersect ENT, Inc. XENT | James E. Flynn | 4,438,213 4.985% | 1,641,180 (+58.68%) | Filing History |
| 2021-02-10 11:03 am Purchase | 2020-12-31 | 13G | Intersect ENT, Inc. XENT | The Vanguard Group | 1,665,434 5.090% | 41,468 (+2.55%) | Filing History |
| 2021-02-10 06:13 am Purchase | 2020-12-31 | 13G | Intersect ENT, Inc. XENT | Artisan Partners Limited Partnership | 2,966,448 9.100% | 2,966,448 (New Position) | Filing History |